STOK

Stoke Therapeutics Reports Full Year 2020 Financial Results and Provides Business Updates

Stoke Therapeutics to Present at the Barclays Global Healthcare Conference

Stoke Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference

Stoke Therapeutics: A Preclinical Biopharma With A Multibillion Dollar Market Cap

Stoke Therapeutics to Present at the Needham Virtual Epilepsy & Pain – Specialty CNS Therapeutics Conference

Stoke Therapeutics Announces Presentations Related to the Company's Work to Advance STK-001, the First Potential New Medicine to Target the Underlying Cause of Dravet Syndrome at the American Epilepsy Society (AES) 2020 Annual Meeting

Stoke Therapeutics Announces Presentations Related to the Company's Work in Dravet Syndrome at the American Epilepsy Society 2020 Virtual Annual Meeting